Senomyx Inc. 

(Public, NASDAQ:SNMX)   Watch this stock   
Find more results for SNMX
Feb 4, 2010
Q4 2009 Earnings Conference Call - Webcast
Feb 4, 2010
Q4 2009 Earnings Release
Jan 13, 2010
Needham & Company 12th Annual Growth Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -148.30% -156.90%
Operating margin -152.32% -164.21%
EBITD margin - -143.24%
Return on average assets -57.79% -40.29%
Return on average equity -108.75% -57.57%
Employees 129 -

Address

4767 Nexus Centre Drive
San Diego, CA 92121
United States - Map
+1-858-6468300 (Phone)
+1-858-4040752 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Senomyx Inc. discussions

  View all discussions »

Description

Senomyx, Inc. is focused on using taste receptor-based assays and screening technologies to discover and develop flavors, flavor enhancers and bitter blockers for the packaged food, beverage and ingredient supply industries. The Company licenses its flavor ingredients to its collaborators on an exclusive or co-exclusive basis. The Company has entered into product discovery and development collaborations with seven packaged food and beverage companies, which include Ajinomoto Co., Inc. (Ajinomoto), Cadbury Schweppes (Cadbury), Campbell Soup Company (Campbell), The Coca-Cola Company (Coca-Cola), Firmenich SA (Firmenich), Nestle SA (Nestle) and Solae LLC (Solae). The Company is pursuing the discovery and development of flavor ingredients through six programs focused on savory, sweet, salt, bitter and cooling taste areas.

Officers and directors

Kent Snyder
Chairman of the Board, Chief Executive Officer
Portrait. Age: 55
Bio & Compensation - Reuters
John Poyhonen
President, Chief Operating Officer
Portrait. Age: 49
Bio & Compensation - Reuters
Tony Rogers
Chief Financial Officer, Vice President
Bio & Compensation - Reuters
Sharon Wicker
Senior Vice President - Commercial Development, Chief Strategy Officer
Age: 53
Bio & Compensation - Reuters
David B. Berger
Vice President, General Counsel, Corporate Secretary
Age: 39
Bio & Compensation - Reuters
David L. Linemeyer Ph.D.
Vice President - Biology
Bio & Compensation - Reuters
Jay M. Short Ph.D.
Lead Independent Director
Age: 50
Bio & Compensation - Reuters
Stephen A. Block Esq.
Director
Age: 64
Bio & Compensation - Reuters
Michael E. Herman
Director
Age: 67
Bio & Compensation - Reuters
Christopher J. Twomey
Director
Age: 49
Bio & Compensation - Reuters